Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth

芦可替尼和 Mcl-1 抑制剂 S63845 在白细胞介素 6 依赖性骨髓瘤细胞中的双重细胞内靶向作用可阻断体内肿瘤生长